# ClearSight System CHN Study

> **NCT03807622** · — · COMPLETED · sponsor: **Edwards Lifesciences** · enrollment: 125 (actual)

## Conditions studied

- Patient With Clinically Indicated Invasive Monitoring

## Interventions

- **DEVICE:** EV1000NI Clinical Platform: Noninvasive Hemodynamic Monitoring utilizing ClearSight System

## Key facts

- **NCT ID:** NCT03807622
- **Lead sponsor:** Edwards Lifesciences
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-12-25
- **Primary completion:** 2019-10-17
- **Final completion:** 2019-10-17
- **Target enrollment:** 125 (ACTUAL)
- **Last updated:** 2019-11-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03807622

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03807622, "ClearSight System CHN Study". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03807622. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*